Name | low density lipoprotein receptor |
Alias |
|
Gene_family | Low density lipoprotein receptors|MicroRNA protein coding host genes |
organism | Homo sapiens |
entrez_id | 3949 |
location | 19p13.2 |
transcript_count | 8 |
exon_count | 19 |
LDLR | APPL1 | 0 | 0 | 66 | 200 | 1 | 1 |
LDLR | AP4M1 | 0 | 0 | 405 | 405 | 1 | 1 |
LDLR | RLN1 | 0 | 0 | 322 | 321 | 1 | 1 |
LDLR | BDP1 | 0 | 0 | 294 | 352 | 1 | 1 |
LDLR | CYP7B1 | 0 | 0 | 294 | 312 | 1 | 1 |
LDLR | APOH | 420 | 540 | 277 | 801 | 1 | 1 |
LDLR | NPC1 | 0 | 0 | 464 | 489 | 1 | 2 |
LDLR | CES3 | 0 | 0 | 386 | 386 | 1 | 1 |
LDLR | NCAN | 0 | 0 | 234 | 234 | 1 | 1 |
LDLR | MMP17 | 0 | 0 | 108 | 171 | 1 | 1 |
PubMed | |||||
---|---|---|---|---|---|
GO:0001540 | Molecular Function | amyloid-beta binding | enables | ISS | |
GO:0001618 | Molecular Function | virus receptor activity | enables | IEA | |
GO:0001920 | Biological Process | negative regulation of receptor recycling | involved_in | IDA | |
GO:0002020 | Molecular Function | protease binding | enables | IPI | |
GO:0005041 | Molecular Function | low-density lipoprotein particle receptor activity | enables | IBA | |
GO:0005041 | Molecular Function | low-density lipoprotein particle receptor activity | enables | IC | |
GO:0005041 | Molecular Function | low-density lipoprotein particle receptor activity | enables | IDA | |
GO:0005041 | Molecular Function | low-density lipoprotein particle receptor activity | enables | IMP | |
GO:0005041 | Molecular Function | low-density lipoprotein particle receptor activity | enables | TAS | |
GO:0005509 | Molecular Function | calcium ion binding | enables | IEA |
Bile acids synthesis and enterohepatic circulation (WP4389) | WikiPathways | WP4389_r123503 |
Cargo recognition for clathrin-mediated endocytosis | Reactome | R-HSA-8856825 |
Cholestasis (WP5238) | WikiPathways | WP5238_r123341 |
Chylomicron clearance | Reactome | R-HSA-8964026 |
Clathrin-mediated endocytosis | Reactome | R-HSA-8856828 |
DNA damage response (only ATM dependent) (WP710) | WikiPathways | WP710_r116542 |
Evolocumab mechanism to reduce LDL cholesterol (WP3408) | WikiPathways | WP3408_r118453 |
Familial hyperlipidemia type 1 (WP5108) | WikiPathways | WP5108_r120390 |
Familial hyperlipidemia type 2 (WP5109) | WikiPathways | WP5109_r120391 |
Familial hyperlipidemia type 3 (WP5110) | WikiPathways | WP5110_r120392 |
Accession | Version | MolecularType | Name | NCBI | Comments |
---|---|---|---|---|---|
NM_000527 | 5 | mRNA | transcript variant 1 | NC_000019 | Reference |
NM_001195798 | 2 | mRNA | transcript variant 2 | NC_000019 | Reference |
XM_011528010 | 3 | mRNA | transcript variant X1 | NC_000019 | Reference |
NM_001195803 | 2 | mRNA | transcript variant 6 | NC_000019 | Reference |
NM_001195800 | 2 | mRNA | transcript variant 4 | NC_000019 | Reference |
NM_001195799 | 2 | mRNA | transcript variant 3 | NC_000019 | Reference |
XM_047438831 | 1 | mRNA | transcript variant X2 | NC_000019 | Reference |
NM_001406861 | 1 | mRNA | transcript variant 7 | NC_000019 | Reference |